Orris

Based in information in this article make short and crisp notes on minoxidil drug for my dermatology practical exam

Reading File
Reading File
Browsing Directory

~/

Running Command

python -c "import pdfplumber; p='/tmp/workspace/attachments/8e94f946-b4dd-44c3-979a-1a175654f19f/Minoxidil in Dermatology.pdf'; pdf=pdfplumber.open(p); print('PAGES',len(pdf.pages)); [print('\\n---PAGE',i+1,'---\\n'+(page.extract_text() or '')) for i,page in enumerate(pdf.pages)]"

Finding Sources
Searching PubMed

minoxidil AND alopecia

Searching the Web

minoxidil topical prescribing information FDA adverse effects

Minoxidil - Short Practical Notes

Class: Potassium-channel opener and arteriolar vasodilator.
Original use: Oral antihypertensive.
Dermatological use: Promotes hair growth.

Mechanism of action

  • Opens potassium channels, causing cell-membrane hyperpolarization and vasodilatation.
  • Increases perifollicular blood flow and may prolong the anagen (growth) phase.
  • May increase VEGF expression and influence prostaglandins/endothelin pathways.
  • Active metabolite: minoxidil sulfate.

Preparations

  • Topical: solution or foam, commonly 2% and 5%.
  • Oral: low-dose minoxidil is used off-label in selected hair disorders.
  • Foam is generally better tolerated than solution, as it may cause less irritation.

Indications in dermatology

Approved/main indication
  • Androgenetic alopecia (male and female pattern hair loss)
    • 5% topical preparation is more effective than 2%.
Off-label uses
  • Alopecia areata, usually adjunctive, with limited benefit in extensive disease.
  • Chronic telogen effluvium.
  • Early traction alopecia.
  • Scarring alopecias including frontal fibrosing alopecia, only as an adjunct to other treatment.
  • Eyebrow and beard enhancement.

Use in combination therapy

May be combined with:
  • Finasteride or spironolactone in appropriate patients.
  • Platelet-rich plasma (PRP).
  • Microneedling.
  • Low-level laser therapy.
Combination treatment may improve hair density and regrowth compared with minoxidil alone.

Pharmacokinetics

  • Topical absorption is low: approximately 1.4% through healthy scalp.
  • Absorption rises with higher concentration, frequent application, and damaged skin barrier.
  • Metabolized mainly in liver; metabolites are excreted by kidneys.

Adverse effects

Topical
  • Scalp irritation, dryness, itching, erythema.
  • Contact dermatitis, often related to vehicle/propylene glycol.
  • Initial transient shedding.
  • Hypertrichosis, especially facial, more frequent with 5% preparation and in women.
Oral
  • Dizziness and postural hypotension.
  • Hypertrichosis.
  • Blood-pressure changes and other systemic vasodilator effects.

Counselling points

  • Apply only to affected scalp and wash hands after application.
  • Results need regular, prolonged use; response varies among individuals.
  • Initial shedding can occur and is usually transient.
  • Hair benefit is generally lost after discontinuation.
  • Review if severe irritation, allergy, dizziness, palpitations, edema, or excessive unwanted hair growth occurs.

One-line viva answer

Minoxidil is a potassium-channel-opening vasodilator used topically in 2% or 5% strength, mainly for androgenetic alopecia; it prolongs anagen and promotes follicular growth, with irritation, initial shedding, and hypertrichosis as important adverse effects.
Based on Hussein et al., “Applications and efficacy of minoxidil in dermatology,” Skin Health and Disease 2024;4:e472, from the provided article.
This is a shared conversation. Sign in to Orris to start your own chat.